BioHealth News Archive

SBIR proposal could open R&D funds to foreign-owned firms

SBIR proposal could open R&D funds to foreign-owned firms

A proposed change in the eligibility rules for the Small Business Innovation Research program could allow foreign-owned companies to compete for these federal research…

Read More
Richard Bendis of BHI interviewed at BIO International Convention

Richard Bendis of BHI interviewed at BIO International Convention

{iframe}http://snnwire.com/Media/index.php/show/richard_bendis_biohealth_innovation_bio_maryland_boston_2012?id=1_64clqei8{/iframe}

Read More
Biotech VCs, in Shadow of Tech, Start Delivering More Hits | Xconomy

Biotech VCs, in Shadow of Tech, Start Delivering More Hits | Xconomy

A strange thing has happened during an otherwise bleak time for biotech venture capital. Life science venture capitalists are apparently hitting more of their…

Read More
Improving Access to Hearing Health Care (SBIR) [R43/R44]

Improving Access to Hearing Health Care (SBIR) [R43/R44]

The purpose of this funding opportunity (FOA) is to improve hearing health care outcomes and reduce health disparities through the development and commercialization of…

Read More
The University of Maryland goes smoke-free – Washington DC College admissions

The University of Maryland goes smoke-free – Washington DC College admissions

This week, the University System of Maryland (USM) announced that smoking would no longer be permitted on any of the 12 USM campuses, including…

Read More
First Lady Michelle Obama and Secretary Kathleen Sebelius announce next chapter of Let’s Move! Cities Towns and Counties

First Lady Michelle Obama and Secretary Kathleen Sebelius announce next chapter of Let’s Move! Cities Towns and Counties

Secretary of Health and Human Services Kathleen Sebelius joined First Lady Michelle Obama and local officials from across the country to announce the next…

Read More
FDA Approves First Drug to Prevent HIV Infection: Scientific American

FDA Approves First Drug to Prevent HIV Infection: Scientific American

US regulators took a step into the unknown this week when they approved the first drug to prevent HIV infection. US Food and Drug…

Read More
SAIC’s $473M aquisition to more than double commercial health care business – Washington Business Journal

SAIC’s $473M aquisition to more than double commercial health care business – Washington Business Journal

Science Applications International Corp.'s $473 million acquisition of maxIT Healthcare Holdings Inc. will more than double the company's commercial health care business and make…

Read More
Humana to support New York City business accelerator

Humana to support New York City business accelerator

Health benefits and health care company Humana Inc. has agreed to sponsor Blueprint Health, a New York City-based business accelerator for entrepreneurs in the…

Read More
Johns Hopkins joins venture to offer free online courses – Baltimore Business Journal

Johns Hopkins joins venture to offer free online courses – Baltimore Business Journal

Johns Hopkins University and 11 other universities are teaming up with a for-profit company founded by two Stanford University computer science professors to offer…

Read More
How to pick useful health apps for mobile devices – The Washington Post

How to pick useful health apps for mobile devices – The Washington Post

Ever wondered whether you should be using your smartphone for something slightly more worthwhile than playing Angry Birds? A growing number of experts are…

Read More

Supervisory Technology Licensing Specialist at Department Of Health And Human Services

The NIH is the premier biomedical research center for the world. Its 27 Institutes and Centers employ approximately 18,000 employees doing a vast array…

Read More
MedImmune to close Santa Clara and Mountain View sites, but will keep Hayward open as it cuts 200 jobs – San Jose Mercury News

MedImmune to close Santa Clara and Mountain View sites, but will keep Hayward open as it cuts 200 jobs – San Jose Mercury News

MedImmune will chop 200 jobs and close its Mountain View and Santa Clara locations, but will beef up its Hayward site, the provider of…

Read More
GlaxoSmithKline to buy Human Genome Sciences for $14.25 per share – Washington Business Journal

GlaxoSmithKline to buy Human Genome Sciences for $14.25 per share – Washington Business Journal

Rockville-based Human Genome Sciences Inc., which rejected a $13-per-share takeover offer from GlaxoSmithKline PLC as too low, has accepted a $14.25 per share offer…

Read More
GlaxoSmithKline wins takeover bid for Human Genome

GlaxoSmithKline wins takeover bid for Human Genome

U.K. drug maker GlaxoSmithKline said Monday it had secured its takeover of Rockville-based Human Genome Sciences after agreeing to pay a higher price for…

Read More